Aimmune Therapeutics
Aimmune Therapeutics Announces Fourth Quarter and Full Year 2015
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001564590-16-013984
- Document
- 8-K
- Exhibit 99.1
- Press release
- Reports quarterly results (2.02)
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2834) and public float not reported.
